Carillo, Virginia C.
HRN: 22-80-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/09/2023
06/09/2023
IV
300mg
1 Hr PTOR
Ameloblastoma
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes